We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Citi analyst Geoff Meacham maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target of $575.00. The company’s shares closed last Friday at ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

announced a three-year strategic research collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to utilize Orna's novel and proprietary LNP delivery solutions to enhance Vertex's ...

Dell, one of the most trusted American laptop manufacturers, has been delivering good-value PCs since its founding in 1987. And PCMag has been testing and reviewing laptops since before Michael ...

As one of the most versatile laptops on the market, Dell's XPS 16 (2024) is also one of the best-designed. Its zero-lattice keyboard and brilliant 4K OLED display make for a striking first ...

If you're wondering what the best Dell XPS deals are or where to find the cheapest prices you've come to the right place. No matter what size or configuration of this incredible Ultrabook you're ...

Despite high valuation risks, VRTX's innovative CF treatments and diversified pipeline make it a compelling long-term investment opportunity. Vertex stock has lagged the market since then ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain drug ...